Surrogacy Market (By Mode of Type: Gestational surrogacy, Traditional surrogacy; By Technology: Intrauterine insemination (IUI), In-vitro fertilization (IVF) [Classical/standard IVF, Intracytoplasmic sperm injection (ICSI)], Others; By Age Group: Below 35 years, 35-37 years, 38 - 39 years, 40-42 years, 43-44 years, Over 44 years; By End User: Hospitals, Fertility clinics, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 190

The global surrogacy market is anticipated to grow at a CAGR of around 6.5% during the forecast period 2020 to 2027 and to reach around US$ 9.5 Bn by 2027.

Market Dynamics

Changing lifestyle pattern is affecting the consumer’s health sometime resulting in infertility, major players are focused on developing advanced solutions, along with rising awareness among consumers is resulting in demand for surrogacy these are major factors expected to drive the growth of global market. According to Centers for Disease Control and Prevention every year, millions of American families struggle with infertility for every 100 couples, 12 to 13 report they’ve experienced trouble getting pregnant. About 7.3 million women of childbearing age in the U.S. have used fertility treatments to get pregnant.  In addition, infertility impacts approximately in 1 in 7 Americans and in 2018, average fertility patient paid over US$ 22,000 per “cycle,” with over 10,000 IVF patients reporting.

Business development activities by major player with the focus to increase the customer base and enhance the profit ration is another factor expected to augment the growth of target market.

  • In 2016, Cooper Surgical Inc. a global healthcare company that deals with health care medical instruments, devices and disposables acquired Wallace Pharmaceuticals located in India. This acquisition is expected to help the company to enhance the product portfolio of IVF.
  • In 2015, Irvine Scientific a global leader in design, manufacture, and distribution of products to the industrial cell culture entered in strategic partnership with Biotech Inc. This partnership is expected to help the company to strengthen its position in US market.
  • In 2019, IVF Spring Fertility Clinic located in India focused on digital marketing campaign in order to create awareness among consumers related to infertility and availability of treatment options. This is expected to create new business opportunities for them and enhance the customer base.
  • In 2017, Genea a leading players in fertility that offers treatments, such as IVF in collaboration with Merck opened Fertility Centre of Excellence in Bangkok. This is expected to help the company to enhance the business presence.

High government spending on development of present healthcare infrastructure for R&D activities along with deployment of advanced equipments in hospitals in order to facilitate the treatment are factors expected to support the growth of target market.

However, factors such as high cost of the procedure and stringent government regulation related to commercial surrogacy are expected to hamper the growth of global surrogacy market. In addition, low success rate of IVF treatment is another factor expected to challenge the growth of target market.

Increasing R&D activities by major players advancements in IVF treatment, along with focus on introduction of cost-effective treatment are factors responsible to create new opportunities for players operating in the target market over the forecast market. In addition, increasing partnership between regional and international players is expected to support the revenue traction of target market.

Segment Analysis by Region

The market in North America is expected to account for significant revenue share owing to large number of patients suffering from infertility issues. In addition, presence of large number of players operating in the country, availability of advanced infrastructure for R&D activities, along with focus on introduction of innovative solutions are factors expected to support the growth of target market.

Increasing merger and acquisition activities for enhancing the customer base and increase the revenue share are factors expected to support the growth of regional market.

Competitive Landscape                                                                                  

The global market is high highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.

Report coverage

Market

 Global Surrogacy Market

Analysis Period

2016 – 2027

Base Year

2019

Forecast Data

2020 – 2027

Market Stratification

Type, Technology, Age Group, End Use and Geography

Regional Scope

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Report Coverage

Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

 

Surrogacy Market Segment Analysis, 2019

The global market is segmented into type, technology, age group, and end use. The technology segment is bifurcated into intrauterine insemination (IUI), in-vitro fertilization (IVF), and others. Among technology the in-vitro fertilization (IVF) segment is expected to account for major revenue share in the global market due to rapid technological advancements by major players.

The end use segment is further divided into hospitals, fertility clinics, and others. The hospital segment is expected to account for significant revenue share in the target segment due to high government spending on development of infrastructure along with availability of reimbursement policies.

The players profiled in the report are Scanfert AVA Clinic, Bourn Hall Fertility Clinic, Nova IVI Fertility, Ovation Fertility, Bangkok IVF Center, Extraordinary Conceptions, Cardone & Associates Reproductive Medicine & Infertility, LLC, New Hope Fertility Center, IVI-RMA Global, Max Healthcare, and Growing Generations, LLC.

Market Segmentation

Market By Mode of Type

Gestational surrogacy

Traditional surrogacy

Market By Technology

Intrauterine insemination (IUI)

In-vitro fertilization (IVF)

  • Classical/standard IVF
  • Intracytoplasmic sperm injection (ICSI)

Others

Market By Age Group

Below 35 years

35-37 years

38 - 39 years

40-42 years

43-44 years

Over 44 years

Market By End User

Hospitals

Fertility clinics

Others

Market By Region

North America

  • US
  • Canada

Europe

  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest if Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Meddle East & Africa


Frequently Asked Questions

The global surrogacy market in 2027 is expected to be above US$ 9.5 Bn.

In end use segment the hospital segment is growing at faster pace.

The CAGR of the global surrogacy market from 2020-2027 is above 6.5%.

In the global market the Asia Pacific region is expected to grow faster.

Some of the players considered in the report scope are New Hope Fertility Center, IVI-RMA Global, Max Healthcare, and Growing Generations, LLC.

Scanfert AVA Clinic, Bourn Hall Fertility Clinic, Nova IVI Fertility, Ovation Fertility, Bangkok IVF Center, Extraordinary Conceptions, Cardone & Associates Reproductive Medicine & Infertility, LLC, New Hope Fertility Center, IVI-RMA Global, Max Healthcare, and Growing Generations, LLC. and others are the prominent players in the surrogacy market.

The surrogacy market is segmented into North America, Europe, Asia Pacific, Latin America and The Middle East & Africa (LAMEA).

Cart Summary


60